Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6Colorectal Neoplasms 4Lung Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Pain 2Motor Activity 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Breast Carcinoma In Situ 2Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sedentary Behavior 1Sarcoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pulmonary Disease, Chronic Obstructive 1Polyps 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Metastatic Pancreatic Adenocarcinoma 1Malignant Hepatobiliary Neoplasm 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Hodgkin Disease 1Hereditary Breast and Ovarian Cancer Syndrome 1

Interventions

Cyclophosphamide 151Dexamethasone 140Rituximab 83fludarabine 78Cytarabine 69Lenalidomide 68Bortezomib 63fludarabine phosphate 62Gemcitabine 62venetoclax 54Etoposide 53pembrolizumab 52pomalidomide 48Paclitaxel 48Cisplatin 47Carboplatin 47Peripheral Blood Stem Cell Transplantation 46Filgrastim 40Radiotherapy 39Calcium Dobesilate 36Busulfan 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 29Vincristine 28Temozolomide 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Recurrence × Telemedicine × Clear all
NCT03794375 2024-10-03

Primary Care Transfer for Thyroid Cancer Patients

Hospital de Clinicas de Porto Alegre

Phase NA Active not recruiting
206 enrolled

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡